drugset / Trial / NCT04390009

Entire-body PET Scans for Multiple Sclerosis

NCT04390009

Phase 0 Recruiting 20 enrolled Brain Health Alliance
Non-randomizedParallel-groupOpen-labelDiagnostic

Summary

To evaluate whether an entire-body positron emission tomography (PET) scanner can be exploited to improve evaluation, monitoring and measurement of both peripheral and central demyelination in multiple sclerosis (MS) patients.

Timeline

Start
2024-09-30
Primary completion
2025-09-30
Completion
2025-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject florbetapir F 18 Diagnostic / imaging agent

Indications